Which has the lower trailing P/E, ABT or MDT?

MDT has the lower trailing P/E: ABT trades at 32.91 and MDT at 22.81. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or MDT?

Over the past five years, MDT grew revenue faster — ABT at a 2.98% CAGR versus MDT at 3.51%.

Does ABT or MDT pay a bigger dividend?

ABT yields 2.43% and MDT yields 3.13% based on trailing dividends and the latest price.

Is ABT or MDT more profitable?

MDT runs the higher net margin — ABT at 11.65% versus MDT at 13.93%.

How have ABT and MDT total returns compared?

Over the past 10 years, ABT delivered 11.61% and MDT delivered 3.40% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Medtronic plc (MDT)

A side-by-side comparison of Abbott Laboratories and Medtronic plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$177.12B

$102.36HealthcareDelayed quote: Sep 16, 2026, 3:59 PM EDT

MDT

Medtronic plc

$118.53B

$92.60HealthcareDelayed quote: Sep 16, 2026, 4:00 PM EDT

Total return — ABT vs MDT

growth of $100 · dividends reinvested · last 10y

ABT +193.7% (+11.4%/yr)MDT +37.9% (+3.3%/yr)ABT compounded faster over this window

ABT MDT

ABT vs MDT: by the numbers

•ABT is the larger company ($177.12B vs $118.53B market cap).
•MDT trades at the lower trailing earnings multiple (22.81 vs 32.91 P/E), one valuation lens rather than an overall verdict.
•MDT converts more revenue to profit (13.93% vs 11.65% net margin).
•MDT grew revenue faster over the past five years (3.51% vs 2.98% CAGR).
•MDT pays the higher dividend yield (3.13% vs 2.43%).

Metrics side by side

Valuation

Metric	ABT	MDT
P/E ratio	32.91	22.81
Forward P/E	18.55	15.50
P/S ratio	3.80	3.16
P/B ratio	3.47	2.36
EV / EBITDA	18.79	15.05
FCF yield	4.47%	5.17%

Profitability

Metric	ABT	MDT
Gross margin	56.80%	66.69%
Operating margin	17.03%	18.08%
Net margin	11.65%	13.93%
ROE	10.61%	10.41%
ROIC	6.07%	6.44%

Dividends

Metric	ABT	MDT
Dividend yield	2.43%	3.13%
Payout ratio	79.74%	70.20%

Growth (annualized)

Metric	ABT	MDT
Revenue CAGR (5Y)	2.98%	3.51%
EPS CAGR (5Y)	8.22%	6.97%
FCF CAGR (5Y)	0.18%	0.93%
Total return CAGR (5Y)	-2.69%	-4.10%

Frequently asked

Which has the lower trailing P/E, ABT or MDT?: MDT has the lower trailing P/E: ABT trades at 32.91 and MDT at 22.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or MDT?: Over the past five years, MDT grew revenue faster — ABT at a 2.98% CAGR versus MDT at 3.51%.
Does ABT or MDT pay a bigger dividend?: ABT yields 2.43% and MDT yields 3.13% based on trailing dividends and the latest price.
Is ABT or MDT more profitable?: MDT runs the higher net margin — ABT at 11.65% versus MDT at 13.93%.
How have ABT and MDT total returns compared?: Over the past 10 years, ABT delivered 11.61% and MDT delivered 3.40% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full MDT analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Medtronic P/E ratio Abbott Laboratories dividend yield Medtronic dividend yield Abbott Laboratories ROE Medtronic ROE Abbott Laboratories operating margin Medtronic operating margin Abbott Laboratories revenue growth Medtronic revenue growth Abbott Laboratories free cash flow Medtronic free cash flow

Abbott Laboratories & Medtronic appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.